About: A pilot study of adalimumab in infliximab-allergic patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A pilot study of adalimumab in infliximab-allergic patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2004

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2004 (fr) наукова стаття, опублікована в липні 2004 (uk) im Juli 2004 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2004 (ast) scientific article published on 01 July 2004 (en)
publication date	wds:Q80844314-989D9466-79DA-4125-850C-DE79F9838677
publication date	2004-07-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q80844314-53E152D4-FE1B-4414-BC22-4CF320013342 wds:Q80844314-563A8A04-BD73-46BB-9EE3-4260EE2CF324 wds:Q80844314-6362BF6A-C763-4915-909E-16470E1C0C63 wds:Q80844314-81BF87AC-1FBE-47B7-8D5C-5E56F98BE83D wds:Q80844314-94B13835-EBB6-49CA-A786-D500002BBAAB wds:Q80844314-A730687C-3A58-4E1D-9E43-41C8925128AE wds:Q80844314-B0A1B8AF-EE65-49C6-B651-73D97D5A9375 wds:Q80844314-BE40A55F-CDA0-46AD-8705-288A2A738C9A wds:Q80844314-C75BCB86-C546-4867-A0B3-DBB5819E9AE3 wds:Q80844314-CDF9BA88-A32F-4C1C-B5B3-94D28CBB6F2B wds:Q80844314-D94E99F0-6486-4002-8165-8FEDF0AF60E7 wds:Q80844314-F0134F46-8598-4A36-94BD-FC3D7220EBC0
author name string	Katie Smith Konstantinos A Papadakis Adrienne Youdim Andrew Ippoliti Eric A Vasiliauskas Marla C Dubinsky Juan Lechago Jason Do Jaime Loane Jane Paavola Joanne Gaiennie Susie K Lee
rdfs:label	A pilot study of adalimumab in infliximab-allergic patients (en) A pilot study of adalimumab in infliximab-allergic patients (nl)
skos:prefLabel	A pilot study of adalimumab in infliximab-allergic patients (en) A pilot study of adalimumab in infliximab-allergic patients (nl)
name	A pilot study of adalimumab in infliximab-allergic patients (en) A pilot study of adalimumab in infliximab-allergic patients (nl)
author	wds:Q80844314-0BDAC8C7-1C9F-42C1-A4DA-ADD595EA4756 wds:Q80844314-4550AFC9-5001-499F-A5F1-427F89151072
author	Stephan R. Targan Maria T Abreu
title	wds:Q80844314-22AB3D6E-D886-4005-A663-0746D3ADB950
title	A pilot study of adalimumab in infliximab-allergic patients (en)
page(s)	wds:Q80844314-68F28452-F414-430A-A012-AEA4B82A4937
page(s)	333-338
instance of	wds:Q80844314-836B8757-4306-472F-8EC7-F6208CCBC879
instance of	scholarly article
main subject	wds:Q80844314-ACCA195C-B671-4C76-BCE8-CFCF030F7AB7
main subject	adalimumab
PubMed ID	wds:Q80844314-99AA12DE-E4B5-4E69-8E53-E2A3CD64E982
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15475739
PubMed ID	15475739
published in	wds:Q80844314-440799F8-FA0F-49CE-AB81-82DFD85673F9
published in	Inflammatory Bowel Diseases
issue	wds:Q80844314-CD89102D-CE13-47C3-B385-2FE734E3CA11
volume	wds:Q80844314-4023E013-1211-4280-9218-DE8D46FE8A7B
issue	4
volume	10
DOI	wds:Q80844314-2C1635C2-412E-4574-B038-371AA2E6D6A3
DOI	http://dx.doi.org/10.1097/00054725-200407000-00002
DOI	10.1097/00054725-200407000-00002
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80844314
is cites work of	Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled study Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study Crohn's disease: a review of current treatment with a focus on biologics. The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy. Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules Current therapy of inflammatory bowel disease in children Treatment with biologic therapies and the risk of cancer in patients with IBD. Practical guidelines for the treatment of inflammatory bowel disease Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease Adalimumab for the treatment of Crohn's disease Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn's Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials. Efficacy and safety of adalimumab in Crohn's disease Effectiveness of infliximab after adalimumab failure in Crohn's disease Anti-TNF-alpha therapy for orofacial granulomatosis: proceed with caution Advances in gastrointestinal pharmacotherapy The Italian clinical experience with adalimumab in Crohn's disease: Eleven clinical cases Adalimumab in Crohn's disease
is cites work of	wds:Q36724676-ECF35BA6-AF99-4100-8B8B-5ACF41D66EBA wds:Q34100121-6AB25891-BEC7-40E1-9277-E698261F1F5E wds:Q37307855-353A5D7C-5D42-4EA1-8972-3419C0500659 wds:Q36310429-70346A02-B15B-4073-A1C1-0F32D8AF7F3A wds:Q35636772-6F43F5F6-14D7-4A43-A14F-2BF38BADD021 wds:Q42844222-49F0EC46-5C96-42B5-9EFC-F4BC8CE2F862 wds:Q51126563-04712A83-A9C4-4F41-A74B-2DB3C2941D06 wds:Q26866940-AEF75EBA-3A3A-4A63-A5C5-74662D4781C3 wds:Q36345271-987A24CC-5DE6-4EB2-B3D2-E62129F5DD6F wds:Q42846582-BDA30F90-A027-4531-87B7-A3737EE190D2 wds:Q34408865-3B5832BA-344B-48A7-BF7C-B6600AFBCE1C wds:Q52561556-6D92ECDA-4A77-4D77-AFC9-A85EE2018BFA wds:Q62476205-96931652-7207-4920-829A-D2CBAFAF9A51 wds:Q37011959-1490B328-60E2-45BD-8555-D738C66208F4 wds:Q37290464-098C7A68-55FC-4AE8-A189-4160FD5D512E wds:Q36579737-1A7C804B-6660-4E8D-8BCB-38AFF97ACD83 wds:Q36622124-624CBB5B-3E99-4BD5-8611-BBB06D99B42C

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software